A new study is out comparing the COVID vaccine from Cambridge-based biotech company Moderna to the one developed by Pfizer.
A new study is out comparing the COVID vaccine from Cambridge-based biotech company Moderna to the one developed by Pfizer.
A new study suggests the COVID-19 vaccine from Moderna generates twice as many antibodies as the vaccine from Pfizer.
The number of COVID-19 cases in children in the US reached levels not seen since the winter surge. Veuer’s Maria Mercedes Galuppo..